03.03.2015 Views

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Clinical <strong>Criteria</strong> with Description, Diagnostic Findings and ICD-9-CM codes<br />

DXCat Number: HEP11<br />

MultiStage: No<br />

DXCat Label: Neoplasm, Malignant: Pancreas Specificity: A<br />

Etiology: Neoplasm<br />

Stage Description Diagnostic findings ICD-9-CM Codes<br />

0.00 Hx, Ca Pancreas History of carcinoma of the pancreas<br />

NO;<br />

1.01 Localized No direct extension of primary pancreatic carcinoma beyond the pancreas [operative/pathology<br />

report<br />

DX 1570-1579;<br />

DX 1570-1579 + DX 1974;<br />

OR pancreatic carcinoma with extension to the duodenum, bile ducts or stomach with no<br />

regional lymph node extension and removal by en bloc excision with the pancreas<br />

[operative/pathology report]<br />

OR Stage I American Joint Committee on Cancer<br />

OR Stage T1<br />

OR Stage T2<br />

2.01 with extension beyond duodenum or bile<br />

ducts or stomach, no regional lymph nodes<br />

Pancreatic carcinoma with extension beyond the duodenum or bile ducts or stomach and no<br />

regional lymph node extension [operative/pathology report]<br />

OR Stage II American Joint Committee on Cancer<br />

OR Stage T3<br />

3.01 with regional lymph nodes Regional node involvement with pancreatic carcinoma [operative/pathology report]<br />

OR Stage III American Joint Committee on Cancer<br />

3.02 with distant or liver mets Liver involvement with pancreatic carcinoma [operative/pathology report]<br />

OR pancreatic carcinoma involves tissue beyond the confines of the abdominal cavity<br />

[operative/pathology report]<br />

OR Stage IV American Joint Committee on Cancer<br />

3.03 with shock Stage 1.01-3.02<br />

AND shock:<br />

4.00 with death Stage 1.01-3.03<br />

AND death<br />

STAGE 1.01 + (DX 1975, 1976,<br />

1978, 3383);<br />

STAGE 1.01-2.01 + (DX 1962,<br />

1966);<br />

STAGE 1.01-3.01 + (DX 1960-<br />

1961, 1963-1965, 1968-1973,<br />

1977, 1980-1991, 78951, 20970-<br />

20979);<br />

STAGE 1.01-3.02 + (GROUP<br />

SHOCKC OR GROUP SHOCKN) ;<br />

NO;<br />

References:<br />

Flanders TY, Foulkes WD. Pancreatic adenocarcinoma: epidemiology and genetics. Journal of Medical Genetics. 1996;33(11):889-98.<br />

Friedman LS. Liver, biliary tract, & pancreas. In: Tierney Jr LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis & Treatment. Stamford, CT: Appleton & Lange;<br />

1998:628-666.<br />

Mayer RJ. Pancreatic Cancer. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. Harrison’s Principles of Internal Medicine.<br />

14th ed. New York, NY: McGraw-Hill; 1998:581-584.<br />

Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet. 1997;349(9050):485-9.<br />

Thursday, January 07, 2010 9:22:18 AM<br />

©2010 Thomson Reuters. All rights reserved.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!